Plant-derived Alkaloids for Diabetes Management: Phytochemistry, Structure-activity Relationships, Molecular Mechanisms, and Medicinal Chemistry Perspectives.
Abstract
Diabetes mellitus is a heterogeneous metabolic disorder that remains a major global health burden. Plant-derived alkaloids constitute a chemically diverse source of candidate antidiabetic leads because their nitrogen-containing scaffolds can engage multiple metabolic and inflammatory pathways. This narrative review, informed by a structured search of PubMed, Scopus, Web of Science, and ScienceDirect through 30 June 2026, integrates phytochemistry, preclinical pharmacology, putative structure-pharmacological activity relationships, and medicinal chemistry considerations for structurally characterized plant alkaloids. Experimentally demonstrated actions across the reviewed compounds include modulation of AMPK and PI3K/Akt/GLUT4 signaling, stimulation of glucose-dependent insulin secretion, inhibition of α-glucosidase and α-amylase, regulation of lipid metabolism, and attenuation of oxidative and inflammatory stress. Because the underlying studies used heterogeneous models, doses, endpoints, and target assays, the recurring structural characteristics identified here- nitrogen ionization state, aromatic conjugation, substituent pattern, ring topology, stereochemistry, and balanced lipophilicity- are presented as proposed determinants rather than validated pharmacophoric requirements. Berberine/protoberberine, harmine/β-carboline, trigonelline/pyridine, lupanine/quinolizidine, and selected quinoline scaffolds emerge as priorities for scaffold-specific optimization. Major translational needs include matched-analogue testing, standardized chronic models, pharmacokinetic-pharmacodynamic analysis, safety and interaction studies, and appropriately designed clinical evaluation.